Synovial Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Condition:   Relapsed or Refractory Synovial Sarcoma Interventions:   Drug: OTSA101-DTPA-111In;   Drug: OTSA101-DTPA-90Y Sponsor:   OncoTherapy Science, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2019 Category: Research Source Type: clinical trials

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Condition:   Synovial Sarcoma Interventions:   Drug: Ramucirumab;   Drug: Gemcitabine;   Drug: Docetaxel Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2019 Category: Research Source Type: clinical trials